BeiGene Ltd (HK:6160) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BeiGene Ltd., a biotechnology company incorporated in the Cayman Islands, has published a new document with the U.S. Securities and Exchange Commission. The announcement, dated September 30, 2024, is a regulatory disclosure required for its securities listed on The Stock Exchange of Hong Kong Limited and follows the company’s obligations under the U.S. Securities Exchange Act of 1934. The company’s leadership, including Chairman John V. Oyler, oversees this compliance as part of its corporate governance.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.